Loading publications…
The last 5 uploaded publications
Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial
Robert Gil, Jacek Bil, Maik J. Grundeken, Adam Witkowski, Luis Iñigo Garcia, Dobrin Vassilev, Tomasz Pawłowski, Radosław Formuszewicz, Sławomir Dobrzycki, Joanna J. Wykrzykowska, Patrick W. Serruys (2016). Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial. EuroIntervention, 12(11), pp. e1404-e1412, DOI: 10.4244/eijy15m11_11.
Article146 days agoLong-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registry
Robert Gil, Jacek Bil, Maik J. Grundeken, Luis Iñigo Garcia, Dobrin Vassilev, Adam Witkowski, Tomasz Pawłowski, Joanna J. Wykrzykowska, Patrick W. Serruys (2016). Long-term effectiveness and safety of the sirolimus-eluting BiOSS LIM® dedicated bifurcation stent in the treatment of distal left main stenosis: an international registry. EuroIntervention, 12(10), pp. 1246-1254, DOI: 10.4244/eijy15m10_05.
Article146 days ago